SK Chemicals’ Vimsk Tab’ became first epilepsy treatment applied for Korean insurance benefit
.jpg)
The SK Chemicals’ epilepsy therapy will be able to secure peerless price competitiveness as registered in Korea for the first time among other same substance products.
SK Chemicals announced ‘Vimsk Tab,’ the first Korean generic of the next generation epilepsy therapy ‘Vimpat Tab(generic name: l...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
